Anticancer potential of Trigonella foenum graecum: Cellular and molecular targets - 04/05/17
, Mounir Ouzir b, 1, Najda Agnieszka c, Loubna Khalki dBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 13 |
| Iconographies | 5 |
| Vidéos | 0 |
| Autres | 0 |
Graphical abstract |
Abstract |
A growing body of evidence supported by numerous studies on tumorigenesis confirms that it is possible to target various hallmarks of cancer. Recent studies have shown that plant-derived molecules may be used in targeting different signaling pathways for cancer drug discovery. The present paper gives an insight into the anticancer potential of fenugreek and lists the existing studies that have been carried out to demonstrate the advantages of the use of fenugreek in cancer treatment and prevention. It also aims at opening up new perspectives in the development of new drugs of natural origins in the future clinical trials. This review article will discuss; (1) the chemical constituents and bioactive compounds of fenugreek; (2) effects on oxidative stress and inflammation; (3) effects on proliferation, apoptosis, and invasion; (4) toxicity of fenugreek; and 5) future directions in cancer drug development. All of the experimental studies discussed in this paper suggest that multiple signaling pathways (hallmarks) are involved in the anticancer activities of fenugreek, but their efficacy is still unclear, which requires further investigation.
Le texte complet de cet article est disponible en PDF.Abbreviations : ABTS, Akt, ALT, ALP, AST, Bak, Bax, Bcl-2, Bcl-xL, Cdc42, C-myc, CNS, COX-2, C-Src, DNA, DPPH, ED50, EGFR, ER, ERK, FADD, Fas, γ-GT, FRAP, HER2, IKK-β, IL-6, IL-1β, iNOS, JAK, JNK, LDH, MAPK, microRNA, MMP, mTOR, MTT, NF-κB, Nrf-2, ORAC, p21, p53, PARP, PCNA, PKC, Raf, Ras, RT-PCR, STAT-3, TGF-β, TIMP-2, TNF-α, TRAIL, Vav2, VEGF
Keywords : Fenugreek, anticancer, cancer hallmarks, drug discovery
Plan
Vol 90
P. 479-491 - juin 2017 Retour au numéro
Article précédent
- The role of SIRT1 in diabetic cardiomyopathy
- Hedyieh Karbasforooshan, Gholamreza Karimi
- Toxicity of triptolide and the molecular mechanisms involved
- Chen Xi, Shaojun Peng, Zhengping Wu, Qingping Zhou, Jie Zhou
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?